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Psychiatric diagnosis
• Clinical
• A quasi-legal document.
• Significant advancement has been made in
phenomenology, diagnostic criteria,
classification, & neurobiology.

Risk syndrome of schizophrenia
• The science of risk syndrome has apparently
matured and
• Its proponents are ready for its inclusion in
DSM V as a diagnosis.
• This may happen or may not happen.
• However it is a welcome agenda for discussion.
• All the stakeholders are curiously watching
• Interest of the ‘patient’ should not be left out.

The symposia will reflect, discuss and
provide synthesis of data to frame an
opinion based upon not only evidence
but also on experience and expectations
of consumers.

Risk Syndrome of Psychosis as a
diagnosis in DSM V:
Is the question legitimate?
Amresh Shrivastava

Schizophrenia – disability and burden
• Economics and mortality
• Prevention of schizophrenia
• approximately 80-85% patients report experiencing
long lasting sub-syndromal symptoms
• Much of functional decline occurs during this
prodromal phase.
• Identification of individuals at prodromal stage of
illness would offer an opportunity for preventive
interventions.

At-risk & prodrome
• Evidence for specific intervention is not very strong,
• At-risk or subthreshold symptoms,
– feel subjective distress
– disability
– Morbidity

•
•
•
•

It is recognized that data available is insufficient
full of ‘non-specificities’.
Concern of inappropriate prescribing and stigmatizing
For prevention of schizophrenia there is no other route
but to identify earliest,

Valid question?
• The present debate presents an opportunity to
examine value of a diagnosis.
• Is a diagnostic category necessary for prevention?
• A position in classification system is a move forward
• opportunity is now
• Significant research progress enough to contest
dismissing the argument.
• research needs to reach clinics.
• In that sense the question appears legitimate.

